INCOME RESEARCH & MANAGEMENT - Q2 2021 holdings

$271 Million is the total value of INCOME RESEARCH & MANAGEMENT's 16 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .

 Value Shares↓ Weighting
 PROSPECT CAP CORPnote 4.950% 7/1$24,788,0000.0%24,212,0000.0%9.14%
-8.6%
 ARES CAPITAL CORPnote 3.750% 2/0$23,761,000
+1.6%
22,738,0000.0%8.76%
-7.2%
 TPG SPECIALTY LENDING INCnote 4.500% 8/0$23,710,000
+6.4%
20,583,0000.0%8.75%
-2.8%
 ILLUMINA INCnote 8/1$23,424,000
+6.1%
18,609,0000.0%8.64%
-3.0%
 FORTIVE CORPnote 0.875% 2/1$22,768,000
-1.1%
22,711,0000.0%8.40%
-9.6%
 SOUTHWEST AIRLS COnote 1.250% 5/0$20,334,000
-11.8%
13,427,0000.0%7.50%
-19.4%
 HERCULES CAPITAL INCdbcv 4.375% 2/0$12,634,000
+3.6%
11,932,0000.0%4.66%
-5.4%
 TEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0$11,848,000
-1.3%
12,028,0000.0%4.37%
-9.8%
 AKAMAI TECHNOLOGIES INCnote 0.125% 5/0$11,372,000
+8.1%
8,701,0000.0%4.20%
-1.2%
 GOLDMAN SACHS BDC INCnote 4.500% 4/0$461,000
-0.4%
450,0000.0%0.17%
-9.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BK OF AMERICA CORP36Q2 20232.1%
WELLS FARGO CO NEW35Q2 20234.0%
ALZA CORP21Q2 20183.9%
FIDELITY NATIONAL FINANCIAL21Q2 20183.8%
TEVA PHARMACEUTICAL FIN LLC21Q2 20185.3%
DANAHER CORP DEL21Q2 20183.8%
JEFFERIES GROUP INC NEW19Q4 20175.5%
OLD REP INTL CORP19Q4 20174.8%
RPM INTL INC19Q2 20184.3%
NOVELLUS SYS INC19Q2 20184.5%

View INCOME RESEARCH & MANAGEMENT's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-25
13F-HR2024-01-19
13F-HR2023-10-24
13F-HR2023-07-21
13F-HR2023-04-20
13F-HR2023-01-31
13F-HR2022-10-20
13F-HR2022-07-21
13F-HR/A2022-04-22
13F-HR2022-04-20

View INCOME RESEARCH & MANAGEMENT's complete filings history.

Compare quarters

Export INCOME RESEARCH & MANAGEMENT's holdings